Search results
Drug targeting clear cell renal cell carcinoma shows promising approach
Newswise· 3 days agoApril 23, 2024 – In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center,...
Allogene secures $15 million grant for cancer trial By Investing.com
Investing.com· 4 hours agoThe funding is earmarked to support the Phase 1 TRAVERSE trial, which is evaluating the safety and...
Analysis identifies 50 new genomic regions associated with kidney cancer risk
Medical Xpress· 1 hour agoIn a new analysis of genetic susceptibility to kidney cancer, an international team of researchers has identified 50 new areas across the genome that are associated with the risk of developing ...
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 21 hours agoOutside the U.S., KEYTRUDA growth was driven by continued uptake in earlier-stage cancers, including high-risk, early stage, triple-negative breast...
New study provides genomic insights into kidney cancer risk
National Cancer Institute· 10 hours agoIn a new analysis of genetic susceptibility to kidney cancer, an international team of researchers...
Moriah Elyse Kerns - Valencia County News-Bulletin
Valencia County News-Bulletin· 1 day agoMoriah Elyse Kerns, age 27, a resident of Los Lunas, passed away on April 20, 2024, as a result of renal cell carcinoma. Moriah was pursuing ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 2 days agoPatients will receive Keytruda or Keytruda plus the vaccine after bladder or kidney removal. Bladder...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 1 day agoKeytruda, the biggest product in Merck’s portfolio, generated sales of $6.95 billion in the quarter,...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Mohave Daily News· 2 days agoSAN FRANCISCO and SUZHOU, China, April 24, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the
Merck highlights progress on HIV, hypertension, cervical cancer drugs
WFMZ Eastern Pennsylvania and Western New Jersey· 23 hours agoMerck got off to an excellent start in the first quarter of 2024. Wall Street met the news with...
